Semler Scientific

Semler Scientific, Inc. is a company that provides technological solutions to enhance the clinical effectiveness and efficiency of healthcare providers. The mission of Semler Scientific is to develop, manufacture, and market innovative products that assist its customers in evaluating and treating chronic diseases. Semler Scientific commercially launched its first patented and FDA-approved product in 2011, and in 2015, it received FDA 510(k) clearance for the next-generation version of the product, QuantaFlo®. QuantaFlo® is a rapid point-of-care test that measures arterial blood flow in the limbs to aid in diagnosing peripheral artery disease. Customers of Semler Scientific use QuantaFlo® to more comprehensively assess patients' risk of heart attack and stroke.